作者:Murat Doğan、Ümit M. Koçyiğit、Meliha Burcu Gürdere、Mustafa Ceylan、Yakup Budak
DOI:10.1007/s12032-022-01784-y
日期:——
negative E values than Imatinib (already used as a drug). For this, in vitro anticancer studies of these molecules were done. The cytotoxic activities of thiosemicarbazone derivatives (3a-y) were evaluated on C6 glioma and MCF7 breast cancer cell lines at 24 h, and Imatinib was used as the positive control. According to the results of the cytotoxicity assay, it can be said that the five compounds (3b
本研究首先合成了22个氨基硫脲衍生物( 3a-y )。然后,利用SwissADME和admetSAR程序对这些分子的ADME参数、药代动力学特性、类药结构和药物化学适用性进行了理论研究。根据这些理论研究的结果,可以说这些化合物的生物利用度和生物活性可能很高。使用 Hex 8.0.0 对接软件分析配体(氨基硫脲衍生物)和靶向蛋白(C6 的蛋白 78 (GRP78) 和醌还原酶 2(MCF 7 的 4ZVM)之间的计算机分子对接。根据对接数据,几乎所有分子都有较高的负E值高于伊马替尼(已用作药物)。为此,对这些分子进行了体外抗癌研究。氨基硫脲衍生物( 3a-y )对C6胶质瘤和MCF7乳腺癌细胞系24 h的细胞毒活性进行了评价,以伊马替尼为阳性对照。根据细胞毒性测定的结果,可以说这五种化合物(3b、c、f、g和m,IC 50 = 10.59–9.08 μg/mL;伊马替尼 IC 50 = 11